441 related articles for article (PubMed ID: 6216459)
21. 99Tcm-MDP and 99Tcm-DPD in pathologic bone lesions. A visual and quantitative comparison.
Lantto T; Vorne M; Mokka R; Vähätalo S
Acta Radiol; 1987; 28(5):631-3. PubMed ID: 2960361
[TBL] [Abstract][Full Text] [Related]
22. Comparison of tc-99m MDP, HMDP, and DPD with respect to bone-to-soft tissue ratios.
Buell U; Kirsch CM; Kleinhans E; Jäger B
J Nucl Med; 1983 Dec; 24(12):1201-2. PubMed ID: 6227711
[No Abstract] [Full Text] [Related]
23. Localization of 99mTc-diphosphonates in newly formed bone matrix as a measure of bone lesion detectability.
Schuemichen C; Krause T; Umbach G; Wolff T
Nuklearmedizin; 1988 Feb; 27(1):8-11. PubMed ID: 3368337
[TBL] [Abstract][Full Text] [Related]
24. Relationship of 99mTc-MDP uptake to regional osseous circulation in skeletally immature and mature dogs.
McKinstry P; Schnitzer JE; Light TR; Ogden JA; Hoffer P
Skeletal Radiol; 1982; 8(2):115-21. PubMed ID: 6213042
[TBL] [Abstract][Full Text] [Related]
25. Which diphosphonate for routine bone scintigraphy (MDP, HDP or DPD)?
Frühling J; Verbist A; Balikdjian D
Nucl Med Commun; 1986 Jun; 7(6):415-25. PubMed ID: 3748485
[TBL] [Abstract][Full Text] [Related]
26. The influence of the method of preparation of the bone scanning agent 99mTc(Sn)EHDP on its tissue distribution in the rat.
Van den Brand JA; Das HA; Dekker BG; de Ligny CL; Van den Hamer CJ
Int J Appl Radiat Isot; 1982 Oct; 33(10):917-28. PubMed ID: 6818161
[TBL] [Abstract][Full Text] [Related]
27. The impact of different bone tracers and acquisition times on image quality of equine bone scintigraphy.
Mageed M; Dyab S; Swagemakers JH; Gerlach K
Vet Radiol Ultrasound; 2022 Sep; 63(5):593-600. PubMed ID: 35666549
[TBL] [Abstract][Full Text] [Related]
28. Bone lesion detection with carrier-added 99mTc-EDTMP in comparison with 99mTc-DPD.
Fueger BJ; Mitterhauser M; Wadsak W; Ofluoglu S; Traub T; Karanikas G; Dudczak R; Pirich C
Nucl Med Commun; 2004 Apr; 25(4):361-5. PubMed ID: 15097810
[TBL] [Abstract][Full Text] [Related]
29. Myocardial uptake of bone scintigraphic agents associated with increased pulmonary uptake.
Bach-Gansmo T; Wien TN; Løndalen A; Halvorsen E
Clin Physiol Funct Imaging; 2016 May; 36(3):237-41. PubMed ID: 25524030
[TBL] [Abstract][Full Text] [Related]
30. Technetium-99m APD compared with technetium-99m MDP as a bone scanning agent.
Degrossi OJ; Oliveri P; García del Río H; Labriola R; Artagaveytía D; Degrossi EB
J Nucl Med; 1985 Oct; 26(10):1135-9. PubMed ID: 4045556
[TBL] [Abstract][Full Text] [Related]
31. Duration of etidronate effect demonstrated by serial bone scintigraphy.
Sandler ED; Parisi MT; Hattner RS
J Nucl Med; 1991 Sep; 32(9):1782-4. PubMed ID: 1908891
[TBL] [Abstract][Full Text] [Related]
32. Primary neuroblastoma uptake of 99mtechnetium methylene diphosphonate.
Smith FW; Gilday DL; Ash JM; Reid RH
Radiology; 1980 Nov; 137(2):501-4. PubMed ID: 6449027
[TBL] [Abstract][Full Text] [Related]
33. The distribution of 99mTc-EHDP in the tissues of the dog and its application in the assessment of fracture healing.
Hughes S
Ann R Coll Surg Engl; 1977 Jul; 59(4):322-7. PubMed ID: 879636
[TBL] [Abstract][Full Text] [Related]
34. The scintigraphy of sacroiliac joints. A comparison of 99mTc-DPD and 99mTc-MDP.
Lantto T
Eur J Nucl Med; 1990; 16(8-10):677-81. PubMed ID: 2143475
[TBL] [Abstract][Full Text] [Related]
35. Bone extraction and blood clearance of diphosphonate in the dog.
Hughes SP; Davies DR; Bassingthwaighte JB; Knox FG; Kelly PJ
Am J Physiol; 1977 Mar; 232(3):H341-7. PubMed ID: 402827
[TBL] [Abstract][Full Text] [Related]
36. Clinical comparison of bone scintigraphy with 99Tcm-DPD, 99Tcm-HDP and 99Tcm-MDP.
Bergqvist L; Brismar J; Cederquist E; Darte L; Naversten Y; Palmer J
Acta Radiol Diagn (Stockh); 1984; 25(3):217-23. PubMed ID: 6236672
[TBL] [Abstract][Full Text] [Related]
37. Blood flow and bone uptake of 99mTc-labeled methylene diphosphonate.
Riggs SA; Wood MB; Cooney WP; Kelly PJ
J Orthop Res; 1984; 1(3):236-43. PubMed ID: 6237181
[TBL] [Abstract][Full Text] [Related]
38. 99mTc-hydroxymethane diphosphonate: a new bone imaging agent with a low tin content.
Domstad PA; Coupal JJ; Kim EE; Blake JS; DeLand FH
Radiology; 1980 Jul; 136(1):209-11. PubMed ID: 6446106
[TBL] [Abstract][Full Text] [Related]
39. Comparative quality control of 99mTc-Pyrophosphate and 99mTc-diphosphonate radiopharmaceuticals.
Jovanović V; Maksin T; Rastovac M; Bzenić J
Eur J Nucl Med; 1983; 8(4):179-82. PubMed ID: 6861787
[TBL] [Abstract][Full Text] [Related]
40. Bone-seeking properties of Tc-99m carbonyl diphosphonic acid, dihydroxy-methylene diphosphonic acid and monohydroxy-methylene phosphoinic acid: concise communication.
Wang TS; Fawwaz RA; Johnson LJ; Mojdehi GE; Johnson PM
J Nucl Med; 1980 Aug; 21(8):767-70. PubMed ID: 7400832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]